To this end, we evaluated the effects on tumor growth in the 4T1 model of treatment with CDDP, Eri, or the combination of both in immunocompetent mice, and then nude (nu/nu) mice, and in mice treated with an anti-CD8–depleting antibody. This evidence concerns the gene CD8A and neoplasm.